SLC5A5 and thyroid gland carcinoma: In previous studies, the immunohistochemistry of thyroid cancer samples revealed that NIS is clearly expressed or even overexpressed in most thyroid cancer cells, but there was a phenomenon of the impaired membrane targeting of NIS and insufficient retention of NIS in the membrane [25,26].